Canadian Kidney Disease Cohort Study: A Study of Hemodialysis Patients
Author Information
Author(s): Bello Aminu K, Thadhani Ravi, Hemmelgarn Brenda, Klarenbach Scott, Gill John, Chan Christopher, Zimmerman Deborah, Holmes Daniel, Cembrowski George, Opgenorth Dawn, Sibrian Rafael, Karkhaneh Mohammad, Tiv Sophanny, Wiebe Natasha, Tonelli Marcello
Primary Institution: University of Alberta
Hypothesis
What are the reversible determinants of adverse outcomes in patients receiving dialysis for end-stage renal disease?
Conclusion
The CKDCS aims to enhance understanding of risk factors for adverse outcomes in dialysis patients through detailed data collection and biological specimen storage.
Supporting Evidence
- The study targets a sample size of 1500 patients to ensure adequate power for exploring multiple research questions.
- Preliminary data from 1074 subjects show that diabetic nephropathy is the leading cause of ESRD.
- The majority of participants live within 50 km of a nephrologist, which may influence access to care.
Takeaway
This study is like a big science project that helps doctors understand why some people on dialysis get sicker, by collecting lots of information and samples from them.
Methodology
The study collects detailed demographic, medical, and laboratory data from all consenting adult hemodialysis patients at five Canadian centers.
Potential Biases
Potential selection bias if not all eligible patients consent to participate.
Limitations
The study may face challenges related to participant consent and the representativeness of the sample.
Participant Demographics
The average age of participants is 62 years, with a majority being white and a significant portion having diabetes and hypertension.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website